Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
44.59
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
28
29
Next >
Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac
December 07, 2022
Via
Benzinga
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
Even a dour outlook for the broader stock market couldn't outweigh good news for these companies.
Via
The Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit.
Via
Benzinga
GSK's Debt Overview
December 06, 2022
Over the past three months, shares of GSK Inc. (NYSE:GSK) moved higher by 19.05%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...
Via
Benzinga
European Official Says COVID-19 Booster Uptake Disappointing In The Region
November 25, 2022
Marco Cavaleri, the European Medicines Agency's (EMA) head of health threats and vaccines strategy, said the recent uptake of COVID-19 vaccine booster doses in the region has been "rather...
Via
Benzinga
GSK Touts Encouraging Data From Mid-Stage Tuberculosis Program In Drug-Susceptible Patients
November 14, 2022
Via
Benzinga
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations
November 11, 2022
Via
Benzinga
Why Vir Biotechnology Jumped Nearly 19% Today
November 04, 2022
A COVID-19 partnership with a major drugmaker is producing more fruit than expected.
Via
The Motley Fool
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection.
Via
Benzinga
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US
November 22, 2022
Via
Benzinga
Dividend Income Update October 2022
November 17, 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio.
Via
Talk Markets
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
Via
Benzinga
Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early
November 03, 2022
Via
Benzinga
GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter Beat
November 02, 2022
Shingrix and specialty medicines helped drive GSK's third-quarter growth.
Via
Investor's Business Daily
GSK Lifts Annual Outlook After Robust Vaccines, Specialty Medicine Sales In Q3
November 02, 2022
Via
Benzinga
GSK's Debt Overview
November 01, 2022
Over the past three months, shares of GSK Inc. (NYSE:GSK) decreased by 16.74%. Before having a look at the importance of debt, let's look at how much debt GSK has.
Via
Benzinga
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting
November 15, 2022
Via
Benzinga
Peering Into GSK's Recent Short Interest
November 15, 2022
GSK's (NYSE:GSK) short percent of float has fallen 11.39% since its last report. The company recently reported that it has 13.36 million shares sold short, which is 0.7% of all regular shares that are...
Via
Benzinga
Daily Stock Analysis: GSK plc
November 15, 2022
By my dogcatcher ideal, this is a likely time to buy GSK plc shares based on their dividends for the coming year 2022-23.
Via
Talk Markets
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
Via
Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care
November 07, 2022
Via
Benzinga
Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex
November 05, 2022
Deals, financings, trials and approvals in Chinese biotech/biopharma this week.
Via
Talk Markets
Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth
November 04, 2022
Sales of Vir Biotechnology and GSK's Covid antibody almost tripled sales estimates.
Via
Investor's Business Daily
Moderna's Earnings Collapsed. Time to Sell?
November 04, 2022
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills.
Via
The Motley Fool
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
November 02, 2022
Reuters
Via
Benzinga
Recap: GSK Q3 Earnings
November 02, 2022
GSK (NYSE:GSK) reported its Q3 earnings results on Wednesday, November 2, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings GSK beat estimated earnings by 15.63%,...
Via
Benzinga
Earnings This Week: AMD, BP And PayPal
October 28, 2022
Find out what to expect from this week's earnings calendar.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
GSK Q3 2022 Earnings Conference Call On November 2, 2022 At 08:00 AM ET
October 28, 2022
GSK (NYSE:GSK) will host a conference call at 08:00 AM ET on November 2, 2022, to discuss Q3 2022 earnings results. How to Attend GSK (GSK) Conference Call Follow this link to access the live webcast.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.